SYK Stryker Corp.

$SYK Stifel cut its Stryker target to 330 from 360 this morning but kept the Buy. The detail worth reading: Stifel's 2026 organic growth estimate, 8.3%, is now the very bottom of Stryker's 8.3 to 9.3% guidance range. Its 14.96 EPS estimate sits basically at the low end of the 14.95 to 15.10 guide. The quarter was fine: Q2 EPS 3.69 vs 3.49 expected, revenue up 9.4% to 6.59 billion. The caution is entirely second-half, orthopedics demand and elective procedure timing. So the call is the guide's floor and the rating is still Buy. Stifel names delayed elective joints and backlog conversion as the upside case. The stock is around 278, down about 29% from the 52-week high.

$SYK so my boss who has a big multi million dollar portfolio managed by this bollion dollar hedge fund put this into his portfolio last month. I was thinking going half or 75% full port. Any idea why I shouldnt?

Stryker Stock In Focus As Truist Says CEO Transition Is Low-Risk, Cuts Price Target To $310 $SYK https://stocktwits.com/news/equity/markets/stryker-stock-in-focus-as-truist-says-ceo-transition-is-low-risk-cuts-price-target-to-310/cZDtfVSRBlf